Levels of interferons are known to increase during the progression of AD from acute to chronic form (40, 41), and elevated transcript levels of IFNγ receptor 1 (Ifngr1) and interferon regulatory factor 9 (Irf9) were observed in the TSLP-challenged vehicle group. Here, TSLP is linked to Alzheimer disease.